Pier 88 Investment Partners LLC cut its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 51.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,690 shares of the company’s stock after selling 5,000 shares during the period. Pier 88 […]
Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average 1-year price […]
TD Cowen lowered shares of 10x Genomics (NASDAQ:TXG – Free Report) from a buy rating to a hold rating in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. TD Cowen currently has $32.00 price target on the stock, down from their prior price target of $57.00. Several other research firms have […]
NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) shares dropped 7.7% on Tuesday after Needham & Company LLC lowered their price target on the stock from $24.00 to $19.00. Needham & Company LLC currently has a buy rating on the stock. NeoGenomics traded as low as $13.70 and last traded at $14.05. Approximately 252,873 shares changed […]
Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) were down 7.7% on Tuesday after Needham & Company LLC lowered their price target on the stock from $24.00 to $19.00. Needham & Company LLC currently has a buy rating on the stock. NeoGenomics traded as low as $13.70 and last traded at $14.05. Approximately 252,873 […]